Viewing Study NCT02842359


Ignite Creation Date: 2025-12-24 @ 2:38 PM
Ignite Modification Date: 2026-01-26 @ 12:18 PM
Study NCT ID: NCT02842359
Status: COMPLETED
Last Update Posted: 2022-04-13
First Post: 2016-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module